VCP
EW icon

Verus Capital Partners’s Edwards Lifesciences EW Stock Holding History

Verus Capital Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Sell
3,511
-489
-12% -$41K 0.02% 375
2026
Q1 		$320K Hold
4,000
– – 0.02% 340
2025
Q4 		$341K Hold
4,000
– – 0.02% 335
2025
Q3 		$311K Sell
4,000
-300
-7% -$23.4K 0.02% 317
2025
Q2 		$336K Hold
4,300
– – 0.03% 272
2025
Q1 		$312K Sell
4,300
-7
-0.2% -$501 0.03% 275
2024
Q4 		$319K Buy
4,307
+7
+0.2% +$490 0.03% 266
2024
Q3 		$284K Hold
4,300
– – 0.03% 275
2024
Q2 		$397K Sell
4,300
-120
-3% -$10.6K 0.04% 218
2024
Q1 		$422K Hold
4,420
– – 0.05% 214
2023
Q4 		$337K Buy
4,420
+59
+1% +$4.11K 0.04% 223
2023
Q3 		$302K Hold
4,361
– – 0.04% 221
2023
Q2 		$411K Sell
4,361
-29
-0.7% -$2.52K 0.06% 186
2023
Q1 		$363K Buy
4,390
+3
+0.1% +$236 0.06% 198
2022
Q4 		$327K Buy
4,387
+57
+1% +$4.39K 0.06% 197
2022
Q3 		$358K Buy
4,330
+2,977
+220% +$286K 0.07% 187
2022
Q2 		$414K Sell
1,353
-2,967
-69% -$307K 0.08% 179
2022
Q1 		$434K Buy
+4,320
New +$485K 0.07% 207
2020
Q1 		$277K Sell
4,410
-300
-6% -$21.6K 0.09% 144
2019
Q4 		$366K Buy
+4,710
New +$368K 0.12% 133

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Verus Capital Partners's EW Position: Q2 2026 in Review

Verus Capital Partners reduced its Edwards Lifesciences (EW) stake by 12% in Q2 2026, selling an estimated $41K and leaving 3,511 shares worth $318K. The position accounts for 0.02% of the portfolio, ranked #375.

Verus Capital Partners first reported a position in EW in Q4 2019 and has held it in 20 quarters since. The position peaked at $434K in Q1 2022. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Verus Capital Partners held 3,511 shares of Edwards Lifesciences worth $318K as of Q2 2026.
  • Verus Capital Partners sold 489 Edwards Lifesciences shares in Q2 2026, an estimated $41K.
  • Edwards Lifesciences made up 0.02% of Verus Capital Partners's portfolio in Q2 2026, its #375 holding.
  • Verus Capital Partners first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 20 quarters since.
  • Verus Capital Partners's Edwards Lifesciences position peaked at $434K in Q1 2022.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Verus Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.